Skip to content
PubMed This is a summary of 58 peer-reviewed journal articles Updated

Research & Literature

Explore the leading researchers and institutions driving advances in this area, and dive into the full body of literature that informs this resource.

Explore the Literature Visualize citation networks across 58 referenced papers

Top Authors

Marina A.J. Tijssen
University Medical Center Groningen
Manju A. Kurian
Great Ormond Street Hospital
Jean‐Pierre Lin
King's College London
Oliviero Bruni
Sapienza University of Rome
Daniel Edward Lumsden
King's College London
Tom J. de Koning
University Medical Center Groningen
Russell Clive Dale
The University of Sydney
Anouk Kuiper
University Medical Center Groningen
Nutan Sharma
Harvard University
Joseph J. Jankovic
Baylor College of Medicine

Top Institutions

Ranked by publications Top 10 institutions

References

References (58)
  1. 1

    Monoamine neurotransmitter disorders--clinical advances and future perspectives.

    Ng J, Papandreou A, Heales SJ, Kurian MA

    Nature reviews. Neurology 2015; (11(10)):567-84 doi:10.1038/nrneurol.2015.172.

    PMID: 26392380
  2. 2

    Pediatric insomnia: new insights in clinical assessment and treatment options.

    Bruni O, Angriman M

    Archives italiennes de biologie 2015; (153(2-3)):144-56 doi:10.12871/000398292015239.

    PMID: 26742668
  3. 3

    Diagnosis of Epilepsy and Related Episodic Disorders.

    St Louis EK, Cascino GD

    Continuum (Minneapolis, Minn.) 2016; (22(1 Epilepsy)):15-37 doi:10.1212/CON.0000000000000284.

    PMID: 26844728
  4. 4

    l-Dopa in dystonia: A modern perspective.

    Maas RPPWM, Wassenberg T, Lin JP, et al.

    Neurology 2017; (88(19)):1865-1871 doi:10.1212/WNL.0000000000003897.

    PMID: 28389587
  5. 5

    Dystonic storm: a practical clinical and video review.

    Termsarasab P, Frucht SJ

    Journal of clinical movement disorders 2017; (4()):10 doi:10.1186/s40734-017-0057-z.

    PMID: 28461905
  6. 6

    A review of psychiatric co-morbidity described in genetic and immune mediated movement disorders.

    Peall KJ, Lorentzos MS, Heyman I, et al.

    Neuroscience and biobehavioral reviews 2017; (80()):23-35 doi:10.1016/j.neubiorev.2017.05.014.

    PMID: 28528196
  7. 7

    Haploinsufficiency of NR4A2 is associated with a neurodevelopmental phenotype with prominent language impairment.

    Reuter MS, Krumbiegel M, Schlüter G, et al.

    American journal of medical genetics. Part A 2017; (173(8)):2231-2234 doi:10.1002/ajmg.a.38288.

    PMID: 28544326
  8. 8

    Status dystonicus in childhood.

    Lumsden DE, King MD, Allen NM

    Current opinion in pediatrics 2017; (29(6)):674-682 doi:10.1097/MOP.0000000000000556.

    PMID: 28937508
  9. 9

    Non-motor symptoms and quality of life in dopa-responsive dystonia patients.

    Timmers ER, Kuiper A, Smit M, et al.

    Parkinsonism & related disorders 2017; (45()):57-62 doi:10.1016/j.parkreldis.2017.10.005.

    PMID: 29066160
  10. 10

    Evaluation and Management of the Child With Autism Spectrum Disorder.

    Baumer N, Spence SJ

    Continuum (Minneapolis, Minn.) 2018; (24(1, Child Neurology)):248-275 doi:10.1212/CON.0000000000000578.

    PMID: 29432246
  11. 11

    A cross-syndrome cohort comparison of sleep disturbance in children with Smith-Magenis syndrome, Angelman syndrome, autism spectrum disorder and tuberous sclerosis complex.

    Trickett J, Heald M, Oliver C, Richards C

    Journal of neurodevelopmental disorders 2018; (10(1)):9 doi:10.1186/s11689-018-9226-0.

    PMID: 29490614
  12. 12

    Crossing barriers: a multidisciplinary approach to children and adults with young-onset movement disorders.

    van Egmond ME, Eggink H, Kuiper A, et al.

    Journal of clinical movement disorders 2018; (5()):3 doi:10.1186/s40734-018-0070-x.

    PMID: 29636982
  13. 13

    A systematic review to explore the feasibility of a behavioural sleep intervention for insomnia in children with neurodevelopmental disorders: A transdiagnostic approach.

    Rigney G, Ali NS, Corkum PV, et al.

    Sleep medicine reviews 2018; (41()):244-254 doi:10.1016/j.smrv.2018.03.008.

    PMID: 29764710
  14. 14

    NR4A2 haploinsufficiency is associated with intellectual disability and autism spectrum disorder.

    Lévy J, Grotto S, Mignot C, et al.

    Clinical genetics 2018; (94(2)):264-268 doi:10.1111/cge.13383.

    PMID: 29770430
  15. 15

    Lethal Factor Domain-Mediated Delivery of Nurr1 Transcription Factor Enhances Tyrosine Hydroxylase Activity and Protects from Neurotoxin-Induced Degeneration of Dopaminergic Cells.

    Paliga D, Raudzus F, Leppla SH, et al.

    Molecular neurobiology 2019; (56(5)):3393-3403 doi:10.1007/s12035-018-1311-6.

    PMID: 30121937
  16. 16

    Home video telemetry in children: A comparison to inpatient video telemetry.

    Carlson S, Kandler RH, Moorhouse D, et al.

    Seizure 2018; (61()):209-213 doi:10.1016/j.seizure.2018.08.028.

    PMID: 30218807
  17. 17

    SPG11 Mutations Associated With a Complex Phenotype Resembling Dopa-Responsive Dystonia.

    Wijemanne S, Shulman JM, Jimenez-Shahed J, et al.

    Movement disorders clinical practice 2015; (2(2)):149-154 doi:10.1002/mdc3.12144.

    PMID: 30363882
  18. 18

    Observing movement disorders: best practice proposal in the use of video recording in clinical practice.

    Sambati L, Baldelli L, Calandra Buonaura G, et al.

    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2019; (40(2)):333-338 doi:10.1007/s10072-018-3639-0.

    PMID: 30448965
  19. 19

    Movement Disorders in Treatable Inborn Errors of Metabolism.

    Ebrahimi-Fakhari D, Van Karnebeek C, Münchau A

    Movement disorders : official journal of the Movement Disorder Society 2019; (34(5)):598-613 doi:10.1002/mds.27568.

    PMID: 30557456
  20. 20

    Utilizing a Prototype Patient-Controlled Electronic Health Record in Germany: Qualitative Analysis of User-Reported Perceptions and Perspectives.

    Poss-Doering R, Kunz A, Pohlmann S, et al.

    JMIR formative research 2018; (2(2)):e10411 doi:10.2196/10411.

    PMID: 30684411
  21. 21

    Voice and swallowing dysfunction in X-linked dystonia parkinsonism.

    Song PC, Le H, Acuna P, et al.

    The Laryngoscope 2020; (130(1)):171-177 doi:10.1002/lary.27897.

    PMID: 30889292
  22. 22

    Current therapies and therapeutic decision making for childhood-onset movement disorders.

    Mohammad SS, Paget SP, Dale RC

    Movement disorders : official journal of the Movement Disorder Society 2019; (34(5)):637-656 doi:10.1002/mds.27661.

    PMID: 30919519
  23. 23

    Applying a User-Centered Approach to Building a Mobile Personal Health Record App: Development and Usability Study.

    Zhou L, DeAlmeida D, Parmanto B

    JMIR mHealth and uHealth 2019; (7(7)):e13194 doi:10.2196/13194.

    PMID: 31278732
  24. 24

    Status dystonicus: management and prevention in children at high risk.

    Iodice A, Pisani F

    Acta bio-medica : Atenei Parmensis 2019; (90(3)):207-212 doi:10.23750/abm.v90i3.7207.

    PMID: 31580306
  25. 25

    Medical management of status epilepticus: Emergency room to intensive care unit.

    Crawshaw AA, Cock HR

    Seizure 2020; (75()):145-152 doi:10.1016/j.seizure.2019.10.006.

    PMID: 31722820
  26. 26

    Copy Number Variations in a Cohort of 420 Individuals with Neurodevelopmental Disorders From the South of Brazil.

    Chaves TF, Baretto N, Oliveira LF, et al.

    Scientific reports 2019; (9(1)):17776 doi:10.1038/s41598-019-54347-z.

    PMID: 31780800
  27. 27

    Loss-of-Function Mutations in NR4A2 Cause Dopa-Responsive Dystonia Parkinsonism.

    Wirth T, Mariani LL, Bergant G, et al.

    Movement disorders : official journal of the Movement Disorder Society 2020; (35(5)):880-885 doi:10.1002/mds.27982.

    PMID: 31922365
  28. 28

    Practice guideline: Treatment for insomnia and disrupted sleep behavior in children and adolescents with autism spectrum disorder: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.

    Williams Buckley A, Hirtz D, Oskoui M, et al.

    Neurology 2020; (94(9)):392-404 doi:10.1212/WNL.0000000000009033.

    PMID: 32051244
  29. 29

    Parkinsonism in children: Clinical classification and etiological spectrum.

    Leuzzi V, Nardecchia F, Pons R, Galosi S

    Parkinsonism & related disorders 2021; (82()):150-157 doi:10.1016/j.parkreldis.2020.10.002.

    PMID: 33109474
  30. 30

    Diagnostic approach to paediatric movement disorders: a clinical practice guide.

    Brandsma R, van Egmond ME, Tijssen MAJ,

    Developmental medicine and child neurology 2021; (63(3)):252-258 doi:10.1111/dmcn.14721.

    PMID: 33150968
  31. 31

    Video quality using outpatient smartphone videos in epilepsy: Results from the OSmartViE study.

    Tatum WO, Hirsch LJ, Gelfand MA, et al.

    European journal of neurology 2021; (28(5)):1453-1462 doi:10.1111/ene.14744.

    PMID: 33465822
  32. 32

    The Clinical Value of Patient Home Videos in Movement Disorders.

    Billnitzer A, Jankovic J

    Tremor and other hyperkinetic movements (New York, N.Y.) 2021; (11()):37 doi:10.5334/tohm.651.

    PMID: 34692230
  33. 33

    Relationship of Genotype, Phenotype, and Treatment in Dopa-Responsive Dystonia: MDSGene Review.

    Weissbach A, Pauly MG, Herzog R, et al.

    Movement disorders : official journal of the Movement Disorder Society 2022; (37(2)):237-252 doi:10.1002/mds.28874.

    PMID: 34908184
  34. 34

    Status Dystonicus in Children: A Cross-Sectional Study and Review of Literature.

    Saini AG, Hassan I, Sharma K, et al.

    Journal of child neurology 2022; (37(6)):441-450 doi:10.1177/08830738221081593.

    PMID: 35253510
  35. 35

    Non-Motor Symptoms in PLA2G6-Associated Dystonia-Parkinsonism: A Case Report and Literature Review.

    Vela-Desojo L, Urso D, Osuna-López M, Hoenicka J

    Journal of clinical medicine 2022; (11(6)) doi:10.3390/jcm11061590.

    PMID: 35329915
  36. 36

    Identifying a minimum data set as a necessity to design a web-based personal health record for patients under chronic dialysis.

    Jeddi FR, Nabovati E, Rezayi S, et al.

    Journal of family medicine and primary care 2022; (11(3)):969-975 doi:10.4103/jfmpc.jfmpc_978_21.

    PMID: 35495826
  37. 37

    NURR1-deficient mice have age- and sex-specific behavioral phenotypes.

    Montarolo F, Martire S, Chiara F, et al.

    Journal of neuroscience research 2022; (100(9)):1747-1754 doi:10.1002/jnr.25067.

    PMID: 35593070
  38. 38

    Two novel heterozygous truncating variants in NR4A2 identified in patients with neurodevelopmental disorder and brief literature review.

    Song X, Xu W, Xiao M, et al.

    Frontiers in neuroscience 2022; (16()):956429 doi:10.3389/fnins.2022.956429.

    PMID: 35992907
  39. 39

    Proband only exome sequencing in 403 Indian children with neurodevelopmental disorders: Diagnostic yield, utility and challenges in a resource-limited setting.

    Pranav Chand R, Vinit W, Vaidya V, et al.

    European journal of medical genetics 2023; (66(5)):104730 doi:10.1016/j.ejmg.2023.104730.

    PMID: 36801247
  40. 40

    Biallelic SHQ1 variants in early infantile hypotonia and paroxysmal dystonia as the leading manifestation.

    Chi CS, Tsai CR, Lee HF

    Human genetics 2023; (142(8)):1029-1041 doi:10.1007/s00439-023-02533-5.

    PMID: 36847845
  41. 41

    [Clinical and genetic characteristics of children with dopa-responsive dystonia caused by tyrosine hydroxylase gene variations].

    Zhang GY, Cai ZJ, Zhang XL, et al.

    Zhonghua er ke za zhi = Chinese journal of pediatrics 2023; (61(4)):339-344 doi:10.3760/cma.j.cn112140-20221118-00987.

    PMID: 37011980
  42. 42

    Diagnosis of autism in a rare case of tyrosine hydroxylase deficiency: a case report.

    Reyes ZMD, Lynch E, Henry J, et al.

    BMC medical genomics 2023; (16(1)):78 doi:10.1186/s12920-023-01510-1.

    PMID: 37041529
  43. 43

    Outcomes of End-User Testing of a Care Coordination Mobile App With Families of Children With Special Health Care Needs: Simulation Study.

    Wong W, Ming D, Pateras S, et al.

    JMIR formative research 2023; (7()):e43993 doi:10.2196/43993.

    PMID: 37639303
  44. 44

    Levodopa for Dystonia in Children: A Case Series and Review of the Literature.

    DeArias AL, Bamford NS

    Pediatric neurology 2024; (152()):16-19 doi:10.1016/j.pediatrneurol.2023.12.012.

    PMID: 38176223
  45. 45

    Chloroprocaine 3% for anesthesia during cesarean section in a patient with dopa-responsive dystonia: A case report.

    Zhou J, Zhou W, Luo D

    Medicine 2024; (103(27)):e38795 doi:10.1097/MD.0000000000038795.

    PMID: 38968521
  46. 46

    Dysphagia is a risk factor of malnutrition in X-linked Dystonia-Parkinsonism.

    Kao TH, Gochyyev P, Sharma N, et al.

    Clinical parkinsonism & related disorders 2024; (11()):100282 doi:10.1016/j.prdoa.2024.100282.

    PMID: 39634363
  47. 47

    Personal Health Record Software for Neuroendocrine Tumors: Patient-Centered Design Approach.

    Hourcade JP, O'Rorke M, Chrischilles E, et al.

    JMIR human factors 2025; (12()):e68788 doi:10.2196/68788.

    PMID: 40460293
  48. 48

    The utility of creatine kinase in status dystonicus and pre-status dystonicus.

    Lumsden DE, Papandreou A, Allen NM, Lin JP

    European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society 2025; (57()):57-63 doi:10.1016/j.ejpn.2025.05.013.

    PMID: 40479934
  49. 49

    Expanding the Clinical Spectrum of NR4A2-Related Disorder: A Systematic Literature Review and Case Series.

    Borden C, Nasir MB, Roberts MB, et al.

    American journal of medical genetics. Part A 2025; (197(10)):e64145 doi:10.1002/ajmg.a.64145.

    PMID: 40497586
  50. 50

    Pediatric Status Dystonicus: A Single-Center 10-Year Retrospective Review.

    Peacock DJSJ, Vithlani K, Clarke GA, et al.

    Movement disorders clinical practice 2025; (12(12)):2247-2252 doi:10.1002/mdc3.70282.

    PMID: 40778528
  51. 51

    Combined molecular characterization and dopa-responsive treatment in two patients with NR4A2-associated intellectual developmental disorder.

    Liang N, Li T, Deng Y

    Frontiers in genetics 2025; (16()):1590292 doi:10.3389/fgene.2025.1590292.

    PMID: 41019763
  52. 52

    A group respite intervention for family caregivers of children living with special needs.

    McGrane C, Martins DC, Geyer D, et al.

    Journal of pediatric nursing 2026; (89()):58-66 doi:10.1016/j.pedn.2026.03.044.

    PMID: 42000702
  53. 53

    Quality of Life and Mental Health Among Families Caring for Children with Medical Complexity: A Scoping Review.

    Suárez-Carrasco A, León-Campos Á, Peláez-Cantero MJ, et al.

    Healthcare (Basel, Switzerland) 2026; (14(9)) doi:10.3390/healthcare14091124.

    PMID: 42121567
  54. 54

    Spiritual well-being, caregiver burden, depression, and quality of life in parents of children with spinal muscular atrophy: A cross-sectional study.

    Cansel N, Özgör B, Yücel G

    Medicine 2026; (105(25)):e49156 doi:10.1097/MD.0000000000049156.

    PMID: 42332491
  55. 55

    Novel Homozygous Pathogenic Variant in DNAJC6 Causes Rapid Progressive Parkinsonism.

    Pessoa ALS, Guimarães TG, de Castro Dos Santos D, et al.

    Movement disorders clinical practice 2026; doi:10.1002/mdc3.70731.

    PMID: 42414182
  56. 56

    Status Dystonicus: An Updated Review on Diagnosis, Pathophysiology, and Management.

    Desai VN, Garg A, Bhattacharya A, et al.

    Annals of Indian Academy of Neurology 2026; (29(4)):501-509 doi:10.4103/aian.aian_1122_25.

    PMID: 42574201
  57. 57

    Sleep in Children with Neurodevelopmental Disorders: From Diagnostic Labels to Phenotype-directed Care.

    Bruni O, Breda M, Mammarella V, et al.

    Current neurology and neuroscience reports 2026; (26(1)).

    PMID: 42635877
  58. 58

    Acute neuro-inflammatory presentation of ATP1A3 variants: Case reports of three patients with different phenotypes.

    Glasson C, Gibaud M, Alesandrini M, et al.

    Archives de pediatrie : organe officiel de la Societe francaise de pediatrie 2026; (33(8)):105616 doi:10.1016/j.arcped.2026.105616.

    PMID: 42763957